drugset / Trial / NCT01794455
Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression
Non-randomizedSingle-groupOpen-labelBasic science
Summary
This pilot proposal will test the hypothesis that altered cerebral vessel reactivity and cerebral hypoperfusion (decreased blood flow to the brain) is a core mechanism underlying the relationship between vascular disease and depression in older adults. The long-term objective of this line of research is to: A) determine the relationship between vascular reactivity, cerebral hypoperfusion and the persistence of late-life depression and B) determine if improving cerebral perfusion with angiotensin receptor blockers (ARBs) improves depression outcomes.
Timeline
- Start
- 2013-05
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Candesartan | Unknown | 32 mg | — |
| Subject | Sertraline | Small molecule | 200 mg | — |